Skip to main content
. Author manuscript; available in PMC: 2025 Mar 24.
Published in final edited form as: J Pharm Sci. 2024 Dec 16;114(2):1164–1174. doi: 10.1016/j.xphs.2024.12.005

Table 3.

Calculated bevacizumab vitreous half-lives in days.

Injection location Case 1a Case 1b Case 2a Case 2b
Rabbit
Anterior vitreous 2.12 0.38 3.26 0.38
Middle vitreous (slow convection) 2.12 0.38 3.27 0.38
Middle vitreous (fast convection) 1.00 0.32 3.27 0.38
Posterior vitreous 2.14 0.38 3.27 0.38
Human
Anterior vitreous 5.29 1.20 10.00 1.27
Middle vitreous (slow convection) 5.36 1.19 10.25 1.27
Middle vitreous (fast convection) 1.62 0.68 10.25 1.27
Posterior vitreous 5.46 1.19 10.56 1.27